Building upon this foundation, the insights gained from our study hold promise for the identification of Ehmt2 as another potential therapeutic target, given its pivotal role in modulating inflammatory responses within the pancreas, thus adding to the growing list of epigenomic targets for intervention in pancreatic diseases. This evidence concerns the gene EHMT2 and pancreas disorder.